VYVANSE 50 MG Israel - English - Ministry of Health

vyvanse 50 mg

medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established

XYLO-POS Israel - English - Ministry of Health

xylo-pos

kivema ltd - xylometazoline hydrochloride - spray - xylometazoline hydrochloride 1 mg/ml - xylometazoline - xylometazoline - rapid relief of nasal congestion for up to ten hours.